AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 71 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $26,021,000 | -86.1% | 2,095,127 | -81.9% | 8.39% | -73.4% |
Q2 2019 | $186,668,000 | -50.7% | 11,594,234 | -3.7% | 31.58% | +3.2% |
Q1 2019 | $378,944,000 | -3.2% | 12,041,419 | +1.0% | 30.59% | -9.7% |
Q4 2018 | $391,631,000 | +18.0% | 11,925,419 | +10.2% | 33.87% | +28.1% |
Q3 2018 | $332,030,000 | +678.6% | 10,825,919 | +580.1% | 26.44% | +411.4% |
Q2 2018 | $42,643,000 | – | 1,591,743 | – | 5.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |